Amant F - Search Results

1

Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.

Amant F, Verheecke M, Wlodarska I, Dehaspe L, Brady P, Brison N, Van Den Bogaert K, Dierickx D, Vandecaveye V, Tousseyn T, Moerman P, Vanderstichele A, Vergote I, Neven P, Berteloot P, Putseys K, Danneels L, Vandenberghe P, Legius E, Vermeesch JR. Amant F, et al. JAMA Oncol. 2015 Sep;1(6):814-9. doi: 10.1001/jamaoncol.2015.1883. JAMA Oncol. 2015. PMID: 26355862

2

Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.

Vergote I, De Smet I, Amant F. Vergote I, et al. Among authors: amant f. Gynecol Oncol. 2002 Mar;84(3):537-8. doi: 10.1006/gyno.2001.6422. Gynecol Oncol. 2002. PMID: 11855893 No abstract available.

3

PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomas.

Amant F, Vergote I. Amant F, et al. Am J Obstet Gynecol. 2002 Jul;187(1):258. doi: 10.1067/mob.2002.124942. Am J Obstet Gynecol. 2002. PMID: 12114928 No abstract available.

4

Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.

Amant F, Huys E, Geurts-Moespot A, Lindeque BG, Vergote I, Sweep F, Schoenmakers EF. Amant F, et al. J Soc Gynecol Investig. 2003 Feb;10(2):105-9. doi: 10.1016/s1071-5576(02)00253-8. J Soc Gynecol Investig. 2003. PMID: 12594000

5

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.

D'Agostino G, Amant F, Berteloot P, Scambia G, Vergote I. D'Agostino G, et al. Among authors: amant f. Gynecol Oncol. 2003 Mar;88(3):266-9. doi: 10.1016/s0090-8258(03)00011-8. Gynecol Oncol. 2003. PMID: 12648573 Clinical Trial.

6

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.

Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M. Amant F, et al. Gynecol Oncol. 2003 Mar;88(3):459-62. doi: 10.1016/s0090-8258(02)00096-3. Gynecol Oncol. 2003. PMID: 12648605 Review.

7

Immunohistochemical determination of hormone receptors in uterine adenosarcomas.

Amant F, Gabriel C, Moerman P, Vergote I. Amant F, et al. Gynecol Oncol. 2003 Mar;88(3):463-4. doi: 10.1016/s0090-8258(02)00006-9. Gynecol Oncol. 2003. PMID: 12648606 No abstract available.

8

Bifunctional pathway of uterine carcinosarcomas.

Amant F, Vergote I. Amant F, et al. Hum Pathol. 2003 Mar;34(3):299; author reply 300. doi: 10.1053/hupa.2003.20. Hum Pathol. 2003. PMID: 12673570 No abstract available.

9

The diagnostic problem of endometrial stromal sarcoma: report on six cases.

Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I. Amant F, et al. Gynecol Oncol. 2003 Jul;90(1):37-43. doi: 10.1016/s0090-8258(03)00207-5. Gynecol Oncol. 2003. PMID: 12821339 Review.

10

Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis.

Amant F, Vloeberghs V, Woestenborghs H, Moerman P, Vergote I. Amant F, et al. Gynecol Oncol. 2003 Aug;90(2):372-7. doi: 10.1016/s0090-8258(03)00326-3. Gynecol Oncol. 2003. PMID: 12893202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

593 results

Search Page

Filters